Advances in the Treatment of High Risk Early Stage Hormone Receptor Positive Breast Cancer
By: William J. Gradishar, MD, FASCO, FACP
CNS METS- Evolving Multidisciplinary Tumor Board Conversations Medical Oncology
By: Andrew Seidman, MD
Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cancer (NO)
By: Cesar A. Santa-Maria, MD, MSCI
Controversy in Breast Cancer- Should be pCR Be an Acceptable Endpoint for Approval of New Therapies for Early-Stage Breast Cancer (NO)
By: Cesar A. Santa-Maria, MD, MSCI
The Integrative Breast Cancer Subtypes: From Relapse Prediction to Novel Targets
By: Christina Curtis, PhD
